Features of the Vascular Endothelium {#S1}
====================================

Vascular endothelium lines the intima of the blood vessels, forming a semi-permeable interface between blood and interstitial fluids. Macromolecules cross this barrier via endo/exocytosis (transcellular permeability), while fluids and small solutes can pass endothelium through the space between adjacent ECs (paracellular permeability) ([@B36]). The permeability of the endothelial layer is finely modulated in order to properly answer local metabolic demands. When the endothelium loses its barrier function, tissue inflammation occurs ([@B46]).

Responsible for paracellular permeability regulation are the intercellular contacts between ECs maintained by AJs, and the cellular adhesion to the underlying matrix through FACs ([@B18]; [@B48]). An enhanced endothelial permeability is the result of loss of contact between adjacent microvascular ECs and weakening of their adhesion to the ECM ([@B48]). Vessel permeability is under the control of pro-inflammatory, thrombogenic mediators and growth factors binding to selective endothelial receptors. A convergent downstream effect is usually an increase of the cytosolic calcium concentration that precedes the enhancement of endothelial permeability. Indeed, cytosolic Ca^2+^ transients induce the retraction of the cell borders by weakening IEJs and cell-matrix junctions. Thus, while ECs change their morphology from a flattened to a rounded shape, gaps between adjacent ECs are formed, allowing the unrestricted flux of plasma proteins, including albumin, and liquid through IEJs ([@B42]; [@B46]; [@B48]).

Transient receptor potential channels play a key role in endothelial calcium fluxes occurring during physiological events and human diseases ([@B33]; [@B93]; [@B10]; [@B26]; [@B87]). Transient receptor potential channels (TRPs) contribute to the regulation of the EB, but the intracellular mechanisms are still partially elusive and highly variable in tissues as well as along the vascular tree.

Here we discuss the state of the art in the field, highlighting the discrepancies and conflicting evidence.

Endothelial Permeability Along the Vascular Tree {#S2}
================================================

Since an increased endothelial permeability is considered a hallmark of vessel growth in many diseases ([@B12]), huge effort is devoted to uncover the underlying mechanisms, especially within the microcirculation.

In resting rat lung, the vascular filtration coefficient (*K*~*fc*~), indicative of the liquid flux, is near 42% in microvessels and just 19% in arterial regions ([@B59]). Similar results were found in canine lung ([@B49]).

Such a striking difference can be ascribed to the density of *fenestrae* ([@B3]), together with EC shape, thickness and the protein composition of the IEJs. Tight junctions are well developed in large vessels, which have a conduct function, while they are weakened along capillaries, the canonical site for exchange with the surrounding tissue. Thus, the number and complexity of tight junctions appear to be inversely related to permeability ([@B3]). Microvascular ECs also express a greater amount of proteins involved in the interaction with the ECM ([@B16]), explaining why the ECM contribution to permeability prevails in capillaries ([@B62]). In addition to these intrinsic mechanisms, also extrinsic factor contribute: blood flow and the relative mechanical stress is pulsatile in large vessels, while linear within capillaries ([@B46]; [@B77]). Finally, capillary permeability is strongly influenced by the coverage by pericytes, contractile cells wrapped around ECs ([@B9]). Indeed, pericytes contraction reversibly opens endothelial gaps, while their loss irreversibly compromises EB ([@B25]). Moreover, pericytes control tight junction expression and alignment ([@B95]).

Calcium Signaling Regulates Endothelial Vessel Permeability {#S3}
===========================================================

Calcium signaling has a central role in the modulation of both physiological and pathological permeability ([@B20]; [@B11]; [@B35]; [@B88]; [@B12]; [@B48]; [@B22]). The intracellular calcium concentration (\[Ca^2+^\]~*i*~) increases in inflammation, causing a reorganization of endothelial gaps ([@B51]; [@B46]).

Calcium signals modulate endothelial permeability partly *via* an ubiquitous mode referred to as SOCE, a calcium influx dictated by the depletion of endoplasmic reticulum (ER) calcium stores. The protein STIM1 is located in ER membranes acting as sensor of Ca^2+^ levels in the lumen: upon ER depletion, it underlies a rearrangement to plasma-membrane-ER junctions, where activates SOCs, that include the pore forming protein Orai1 ([@B74]) and members of the TRP channel superfamily ([@B15]; [@B6]).

Inflammatory mediators (e.g., thrombin and histamine) bind to plasma membrane G protein-coupled receptors and trigger InsP3-dependent Ca^2+^ release from ER and the following SOCE. The calcium-mediated phosphorylation of MLC drives the formation of actomyosin contractile units and stress fibers, which exert force on the IEJs, weakening them ([@B24]; [@B70]; [@B13]). In addition, PKC phosphorylates junctional linking proteins vinculin and talin in IEJs and FACs ([@B42]; [@B64]; [@B65]). The disassembly of cell-cell and cell-matrix contacts (PKC-mediated passive cell retraction) and the concomitant establishment of contractile units (MLCK-mediated active cell contraction) lead to ECs rounding as well as the formation of intercellular gaps and permeability enhancement.

Early studies highlighted a variable contribution of calcium signaling to vascular permeability between larger and smaller vessels. [@B35] showed that an increase of \[Ca^2+^\]~*i*~ enough to promote permeability in rPAECs, failed to exert any effect on rPMECs, initially suggesting an apparent uncoupling of \[Ca^2+^\]~*i*~ signaling pathways or dominant Ca^2+^-independent mechanisms in microvasculature. *In vitro* permeation studies showed that the phosphodiesterase-4 inhibitor Rolipram inhibits SOC in PAECs while revealing it in PMVECs, with consequent shift of the fluid leakage site from big vessels to the microcirculation. Thus, the intracellular events associated with SOCE appear to be site specific, according to the variability of the response to proinflammatory stimuli ([@B24]; [@B97]).

More recently, nSOCs were proposed as major players in microvascular permeability ([@B5]; [@B17]; [@B37]; [@B60]). Activated following agonist stimulation and independently of store depletion, nSOCs regulate EB ([@B46]).

Trps in Endothelial Permeability {#S4}
================================

Transient receptor potential channels are a superfamily of ion channels, which regulate the plasma membrane permeability to cations in response to a broad range of stimuli. Importantly, 19 of the 28 mammalian TRP channel isoforms are expressed in vascular ECs. Among them, all of the TRPC; TRPV1, -V2, and -V4; all of the TRPM except -M5; and TRPP1 and -P2 ([@B98]; [@B38]).

In the following paragraphs, research works that discuss the role of TRP channels in the regulation of EC permeability will be discussed.

The involvement of TRPs in EB regulation is well established ([@B28]; [@B57]; [@B63]; [@B84]; [@B50]; [@B56]). TRPs can be activated by both intra- and extra-cellular messengers, as well as by physical or mechanical stimuli, promoting calcium signals and membrane depolarization, that may respectively, recruit store-operated and voltage-gated channels ([@B54]; [@B53]).

Consistent literature supports the involvement of TRP channels in both SOCE and non-SOCE calcium entry in ECs, as well as in endothelial permeability.

The molecular identity of the channels involved in endothelial SOCE gave rise to a long and exciting debate, with conflicting data due to methodological issues as culture conditions, overexpression systems, electrophysiological protocols, and pharmacological approaches ([@B28]; [@B1]; [@B86]). The general accepted model recognizes highly Ca^2+^ selective SOCE currents through Orai1 channels and non-selective SOCE currents (the canonical I~*SOC*~) mediated by Orai1 and TRPC1, considered the predominant isoform expressed in human vascular endothelium ([@B84]; [@B96]; [@B15]; [@B68]; [@B6]; [@B41]). The ER Ca^2+^ sensor STIM1 regulates both these kinds of channels ([@B41]) and triggers Orai1 and TRPC1 activation by distinct C-terminus domains. Therefore, TRPC1 function is not only dependent on STIM1, but also requires the interaction with Orai1 ([@B56]). Moreover, Orai1-mediated Ca^2+^ entry is needed for recruitment of TRPC1 and its insertion into membranes, while STIM1 gates the channel ([@B15]). In human ECs, the phosphorylation of TRPC1 by PKCa is essential for the thrombin-induced activation of SOCE ([@B2]). The expression of TRPC1 is also regulated: in human PAECs (hPAECs), the inflammatory cytokine TNF-α promotes TRPC1 overexpression ([@B58]) that triggers Ca^2+^ influx and enhances endothelial permeability ([@B84]). Upon thrombin exposure, RhoA triggers the association of TRPC1 to InsP3R, its translocation to the plasma membrane, calcium entry enhancement and finally the increase in endothelial permeability ([@B45]). A role for SPHK1 was suggested in the pathway by which TRPC1-mediated calcium entry destabilizes AJs: TRPC1 holds SPHK1 constitutively in a suppressed state to prevent SP1 production, enabling inflammatory agonists to mediate vascular leak ([@B80]; [@B72]).

TRPC1 overexpression in hMEC caused a twofold increase in thrombin-induced calcium depletion and in InsP3 store-operated cationic current. Actin-stress fiber formation was augmented and TER decreased ([@B58]). On the contrary, TRPC1 depletion reduced the global cytosolic Ca^2+^ response by 25% and *I*~*SOC*~ by 50% ([@B14]). Further, the application of a specific antibody directed against an extracellular epitope of TRPC1 blocked thrombin- or InsP~3~-induced Ca^2+^ entry ([@B2]).

Some members of TRPC family (i.e., TRPC-3, -6, and -7) can be stimulated by the membrane-permeant analog of DAG, 1-oleoyl-2-acetyl-sn-glycerol ([@B32]). Furthermore, these three channels show different levels of store-dependence: TRPC-3 is quite sensitive to InsP3-mediated responses, whereas TRPC-6 and -7 appear to be completely store-independent. Nevertheless, the independence of TRPC-3 from InsP3 receptor activation has been demonstrated in that PLC activation in InsP3 receptor-deficient cell lines still retained TRPC-3 activation ([@B85]; [@B61]).

Beside TRPC1, TRPC4 was also proposed as a major contributor in SOCE ([@B97]; [@B86]; [@B78]; [@B7]). TRPC1 and TRPC4 can heterodimerize in ECs, forming a single functional channel ([@B8]; [@B43]; [@B23]; [@B27]). TRPC4 binds to STIM1 ([@B96]) as well as to Orai1: interestingly, Orai1 knockdown decreases the opening probability and the selectivity of TRPC1/4 channel ([@B19]; [@B81]).

Knock out models for TRPC4 confirmed its role in permeability *in vivo*. Ca^2+^ influx evoked either by thrombin or a synthetic agonist (TFLLRNPNDK) was drastically diminished in isolated-perfused TRPC4-/- mouse lungs and in cultures ECs from the same model ([@B85]). This was associated with a lack of thrombin-induced actin-stress fiber formation and an impaired endothelial cell retraction.

Interestingly, TRPC4/5 channels can be mobilized not only *via* the Gq/11-protein--PLC pathway, but also following Gi/o-coupled signaling ([@B34]).

Even if not demonstrated in ECs, recent evidences show that TRPC4/5 recruitment requires the dissociation of NHERF proteins from the channel C terminus, thus providing DAG sensitivity ([@B76]; [@B44]).

As stated above, TRPC6 may also be involved in EB dysfunction. Indeed, in frog mesenteric microvessels, VEGF-induced increase in vascular permeability can be mimicked by DAG, an agonist of TRPC3/6/7. Furthermore, flufenamic acid, which positively regulates TRPC6 but inhibits -C3 and -C7, enhances the effect exerted by VEGF ([@B61]).

Evidences from studies with transfected cells demonstrated the TRPCs can mediate Ca^2+^ gated by DAG and are store and PKC independent ([@B55]). Consistently, OAG-induced Ca^2+^ currents in TRPC-6-expressing cells were not sensitive to PKC inhibition, suggesting that TRPC-6 is directly gated by DAG ([@B32]).

Moreover, in [@B61] demonstrated *in vivo* that at least one mechanism of action of VEGF involves the increase in \[Ca^2+^\]~i~ through store-independent TRPC-6 activation.

Finally, by the use of calcium imaging in isolated perfused rat lungs and patch clamp in rPAECs, TRPC6 was found to be critically involved in lung vascular leakage after stimulation with platelet-activating factor through its recruitment into caveolae ([@B69]). In human PAECs, cell contraction exerted by thrombin is mediated by TRPC6 *via* a PKA-dependent pathway ([@B73]).

A member of TRPM subfamily, TRPM2, is highly expressed in ECs ([@B72]), but its role in permeability is controversial. In cultured hPAECs, TRPM2 is opened by intracellular ADP-ribose and mediates the hyperpermeability triggered upon exposure to H~2~O~2~. Some *in vivo* studies reported that TRPM2^--/--^ mice develop pulmonary edema upon LPS treatment ([@B82]), but other authors failed to reproduce the evidence ([@B31]). The discrepancy could be due to different mouse strains used in the experiments ([@B81]).

In the ECs of blood vessels following spinal cord injury, TRPM4 resulted up-regulated, but the underlying mechanism in vascular permeability remains unclear ([@B29]).

Finally, some components of TRPV subfamily are under intense investigation.

The role of TRPV1 channels in this context is controversial. Indeed, Alvarez et al. demonstrated that the TRPV1 agonists did not affect lung permeability ([@B4]). Nevertheless, Wang et al. reported a protective effect by capsaicin, a potent TRPV1 activator, in rabbit lung ischemia-reperfusion injury ([@B91]; [@B81]). On the other hand, TRPV1 expression is very low in hMECs ([@B82]).

Nowadays, TRPV4 is attracting much attention for its influence on capillary barrier function ([@B52]; [@B72]). Downregulation of TRPC1 and TRPC4 in artery and vein lung endothelium is associated with the loss of response to the SOCE-activating compound thapsigargin, supporting the idea that thapsigargin triggers a TRPC1/TRPC4-containing channel to increase permeability. However, permeability regulated by EET, a metabolite of the AA, was retained, opening the possibility for the involvement of other channels ([@B4]). 14,15-EET, which is produced upon high peak inspiratory pressure, activates TRPV4 and the subsequent increase in pulmonary vascular permeability ([@B92]; [@B30]; [@B72]; [@B81]). TRPV4 is abundantly expressed in the endothelium from lung intra-alveolar capillaries and, to a lesser extent, from large, extra-alveolar vessels ([@B21]; [@B5]). The TRPV4 agonist 4αPDD increased permeability in wild type capillaries, with disruption of cell-matrix tethering, but failed to exert any effect in TRPV4 knockout mice; on the other hand, thapsigargin produced the same effect in extra-alveolar vessels ([@B5]; [@B81]). Therefore, TRPC1 and TRPC4 appear to interfere preferentially with the lung extra-alveolar EB, whereas TRPV4 is prominently functional in lung capillaries ([@B17]). In mice, TRPV4 knockout prevented the permeability increase of lung microvasculature induced by both 4αPDD and 14,15-EET, without affecting SOCE ([@B37]). Moreover, TRPV4 triggers Ca^2+^-activated K^+^ channels (KCa) in rPMECs, enhancing the driving force for calcium entry and the response to TRPV4 ([@B40]). In mouse and human LMECs, ROS enhance vessel permeability *via* a Fyn Src kinase-TRPV4-dependent Ca^2+^ influx ([@B79]; [@B81]). TRPV4 seems to be also involved in the pulmonary edema associated with heart failure ([@B83]). Interestingly, a NO/cGMP-dependent negative feedback loop was discovered for protection against the excessive microvascular barrier permeability ([@B99]). In LMECs, mechanically gated recruitment of TRPV4 elicits the release of the MMP MMP2 and MMP9, which degrade collagen IV and laminin, key structural components of the alveolar basement membrane, as well as integrins, intercellular E-cadherin and other intercellular targets ([@B89]). The overall effect is the endothelial detachment from the basement membrane ([@B94]; [@B90]) and a permeability enhancement.

TRPV4 is also expressed in retinal hMECs and in intact blood vessels of the inner retina. Its selective agonist GSK101 promoted MEC permeability in association with disrupted F-actin organization, occludin downregulation and adherent contacts remodeling. Moreover, GSK101 increased the permeability of WT retinal blood vessels, but not in TRPV4 knockout mice, pointing to a major role for the channel in Ca^2+^ homeostasis and retinal barrier function ([@B60]).

Conclusion {#S5}
==========

Calcium signaling tunes endothelial permeability in capillaries as well as in larger vessels. However, it is not surprising to find a huge variability in the related molecular machinery due to the well known heterogeneity of the endothelium in different tissues ([Figure 1](#F1){ref-type="fig"}).

![Regulation of endothelial permeability by TRP channels. The endothelial calcium signals regulate vascular permeability in large vessels as well as in capillaries through different mechanisms.](fphys-11-00421-g001){#F1}

A general and established model for the relative contribution of SOCE and non-SOCE in macro- and micro-vessel permeability, as well as for the identity and function of TRP channels, is not available yet. A severe limitation is the lack of a detailed TRP proteomic pattern and intracellular targeting landscape in capillary and arterial/vein ECs. In addition, selective pharmacological compounds are only available for some TRP members and some of them are not suitable for systemic treatments due to their highly toxicity ([@B47]; [@B66]; [@B67]; [@B39]).

Finally, the simple detection of a variety of active calcium entry mechanisms, with their complex protein machineries, does not necessarily provide an evidence for their exclusive functional involvement in vessel permeability. Trebak and coworkers reported that the acute barrier disruption activated by thrombin in hUVECs and hMECs requires endoplasmic-reticulum localized STIM1 independently of Orai1, MLCK, and Ca^2+^ entry across the plasma membrane. STIM1 couples the thrombin receptor, recruits guanosine triphosphatase RhoA and stimulates MLC phosphorylation, finally leading to formation of actin stress fibers and loss of cell-cell adhesion ([@B71]; [@B75]).

Vascular permeability is probably the result of a concurrence among diverse, tissue-dependent intracellular processes, all contributing in variable weights to the overall event.
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4 α PDD

:   4 α-phorbol 12,13-didecanoate

AA

:   arachidonic acid

AJs

:   adherent junction complexes

EB

:   endothelial barrier

ECM

:   extracellular matrix

ECs

:   endothelial cells

EET

:   14,15-epoxyeicosatrienoic acid

FACs

:   focal adhesion complexes

hMEC

:   human microvascular endothelial cells

IEJs

:   intercellular endothelial junctions

LMECs

:   lung microvascular EC

MLC

:   Myosin light chain

MMP

:   matrix metalloproteinases

nSOCs

:   non-store-operated channels

ROS

:   reactive oxygen species

rPAECs

:   rat pulmonary aortic endothelial cells

rPMECs

:   rat pulmonary microvascular endothelial cells

SOCE

:   Store-Operated Calcium Entry

SOCs

:   store-operated cation channels

SP1

:   sphingosine-1-phosphate

SPHK1

:   sphingosine kinase 1

TER

:   transendothelial electrical resistance

TNF- α

:   tumour necrosis factor- α

TRP

:   Transient receptor potential.
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